Meta-analysis of the acute effects of nicotine and smoking on human performance.
Level 1 - systematic review of randomized trials
Meta-analysis of double-blind, placebo-controlled laboratory trials
PubMed 20414766 · doi:10.1007/s00213-010-1848-1
What was done
The authors conducted a meta-analysis of 41 double-blind, placebo-controlled laboratory studies published between 1994 and 2008. Participants were healthy adult nonsmokers or smokers who were minimally deprived (≤2 hours) or not deprived of tobacco. Nine performance domains were evaluated, covering motor abilities, alerting and orienting attention, and episodic and working memory.
What was found
Significant positive effects of nicotine or smoking were detected across six of the nine domains: fine motor, alerting attention-accuracy and response time (RT), orienting attention-RT, short-term episodic memory-accuracy, and working memory-RT. Reported effect sizes across significant domains ranged from 0.16 to 0.44. Exact domain-specific effect sizes, confidence intervals, and p-values were not reported in the abstract.
Why it matters
This review shows that nicotine produces genuine acute performance enhancements independent of withdrawal relief, helping clarify cognitive mechanisms underlying tobacco use initiation and maintenance.
Limits
The abstract does not state the total number of human participants or details regarding the three non-significant domains. The findings are restricted to acute, laboratory-tested tasks and cannot be directly generalized to chronic use patterns or real-world complex cognitive functioning.
Cited by
- context Paul Newhouse's research at Vanderbilt University found that nicotine does not enhance cognition in healthy individuals who sleep and eat well.
- supports A 2010 meta-analysis by Heishman of 41 double-blind placebo-controlled trials found cognitive effect sizes of nicotine supplementation ranged from 0.16 to 0.44.